Lofibra 134 mg Gate 323 Pill - blue capsule/oblong, 18mm

Generic Name: fenofibrate

Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule/Oblong and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of Hypertriglyceridemia; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lofibra 134 mg Gate 323

Lofibra

Generic Name: fenofibrate
Imprint: Lofibra 134 mg Gate 323
Strength: 134 mg
Color: Blue
Size: 18.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Gate Pharmaceuticals
National Drug Code (NDC): 57844-0323 (Discontinued)
Inactive Ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, titanium dioxide
Note: Inactive ingredients may vary.